PMA device
Alere NMP22 Urine Collection Kit
Abbott Diagnostics Scarborough, Inc. · System, Test, Tumor Marker, For Detection Of Bladder Cancer (NAH, Class III) · First FDA decision Jan 20, 2012, newest Jan 20, 2012Bladder cancer
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "Alere NMP22 Urine"
MAUDE reports
0
Brand "Alere NMP22 Urine", since 2015
PubMed studies
0
Mentioning "Alere NMP22 Urine"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Alere NMP22 Urine Collection Kit
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- ALERE NMP22 URINE COLLECTION KITPMA supplement
P940035-S007 · Decided Jan 20, 2012 · 177 days after receipt · Normal 180 Day Track No User Fee
Device type: System, test, tumor marker, for detection of bladder cancer (NAH) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- MolDX: Phenotypic Biomarker Detection from Circulating Tumor CellsLocal determinationIn effectL38678WPS Insurance CorporationUpdated Jun 18, 2026
- MolDX: Phenotypic Biomarker Detection from Circulating Tumor CellsLocal determinationIn effectL38584CGS Administrators, LLCUpdated Apr 6, 2026
- Bladder/Urothelial Tumor MarkersLocal determinationIn effectL36975CGS Administrators, LLCUpdated Feb 20, 2026
- MolDX: Phenotypic Biomarker Detection from Circulating Tumor CellsLocal determinationIn effectL38643Noridian Healthcare Solutions, LLCUpdated Jan 26, 2026
- Lab: Bladder/Urothelial Tumor MarkersLocal determinationIn effectL36678Noridian Healthcare Solutions, LLCUpdated Oct 27, 2025
- MolDX: Phenotypic Biomarker Detection in Circulating Tumor CellsLocal determinationIn effectL38566Palmetto GBAUpdated Jun 24, 2025
- Lab: Bladder/Urothelial Tumor MarkersLocal determinationIn effectL33420Palmetto GBAUpdated Feb 25, 2021
- Screening for Colorectal Cancer-Non-Invasive Biomarker TestsNational analysisReview closedCAG-00440RUpdated Sep 22, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Alere NMP22 Urine", any status and sponsor, newest update first.
No registered device study names "Alere NMP22 Urine".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Alere NMP22 Urine", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NAH
1 reports: 0 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Alere NMP22 Urine"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NAH.
- NMP22 BladderChek TestAbbott Diagnostics Scarborough, Inc. · PMA 2022
- Alere NMP22 Bladdercheck Test & Control KitAbbott Diagnostics Scarborough, Inc. · PMA 2012
- NMP22 Elisa Test KitAbbott Diagnostics Scarborough, Inc. · PMA 2008
- Matritech NMP22 Test KitAbbott Diagnostics Scarborough, Inc. · PMA 2000
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.